Baker Tilly Wealth Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,773	Closed	-$212K	–	525
2021 Q3	$212K	Buy	11,773 +34	+0.3%	+$612	0.03%	482
2021 Q2	$206K	Hold	11,739	–	–	0.03%	477
2021 Q1	$296K	Buy	+11,739	New	+$296K	0.06%	360